Literature DB >> 25575958

Region-specific pro-survival signaling and global neuronal protection by wild-type Huntingtin.

Caodu Buren1, Liang Wang1, Amy Smith-Dijak1, Lynn A Raymond2.   

Abstract

BACKGROUND: Huntington's disease (HD), caused by polyglutamine expansion in huntingtin (Htt), results in severe neurodegeneration in the striatum, and to a lesser extent, cortex and hippocampus. In contrast, non-expanded huntingtin (wildtype, wtHtt) enhances pro-survival trophic factor BDNF expression and protects striatal neurons from excitotoxicity, a mechanism thought to contribute to HD pathophysiology; however, it is unknown whether these effects of wtHtt extend to other brain areas.
OBJECTIVE: Test wtHtt's role in pro-survival signaling and neuroprotection in striatum, cortex and hippocampus.
METHODS: Levels of nuclear phosphorylated cAMP response element-binding protein (pCREB), a regulator of pro-survival gene transcription, and resistance to NMDA-induced apoptosis in primary neuronal cultures - hippocampal and corticostriatal co-culture -were assessed using immunocytochemistry and excitotoxicity assays, respectively. Cultures from wild-type FVB/N (WT) mice were compared with those from YAC18 mice on an FVB/N background, expressing both human, full-length wtHtt and normal levels of murine Htt.
RESULTS: Basal pCREB was higher in YAC18 striatal but not cortical or hippocampal neurons; however, all three types showed decreased apoptosis in YAC18 vs. WT cultures. Increased striatal neuronal pCREB required wtHtt overexpression in both cortical and striatal neurons. Reduced response to exogenous BDNF, or its soluble scavenger TrkB-Fc, suggested enhanced BDNF signaling contributes to increased YAC18 striatal pCREB.
CONCLUSION: Basal pro-survival signaling does not predict neuronal vulnerability to apoptosis in our culture system, since wtHtt overexpression elevates basal pCREB selectively in striatal neurons but is more globally neuroprotective. These results extend knowledge of the physiological roles of huntingtin, facilitating development of HD therapeutics.

Entities:  

Keywords:  Wild-type huntingtin; excitotoxicity; neuroprotection; pCREB

Mesh:

Substances:

Year:  2014        PMID: 25575958     DOI: 10.3233/JHD-140122

Source DB:  PubMed          Journal:  J Huntingtons Dis        ISSN: 1879-6397


  4 in total

Review 1.  Recent Advances in the Treatment of Huntington's Disease: Targeting DNA and RNA.

Authors:  Kathleen M Shannon
Journal:  CNS Drugs       Date:  2020-03       Impact factor: 5.749

2.  Influence of cortical synaptic input on striatal neuronal dendritic arborization and sensitivity to excitotoxicity in corticostriatal coculture.

Authors:  Caodu Buren; Gaqi Tu; Matthew P Parsons; Marja D Sepers; Lynn A Raymond
Journal:  J Neurophysiol       Date:  2016-04-27       Impact factor: 2.714

Review 3.  Transcriptional Dysregulation and Post-translational Modifications in Polyglutamine Diseases: From Pathogenesis to Potential Therapeutic Strategies.

Authors:  Chunchen Xiang; Shun Zhang; Xiaoyu Dong; Shuang Ma; Shuyan Cong
Journal:  Front Mol Neurosci       Date:  2018-05-15       Impact factor: 5.639

4.  HuR stabilizes HTT mRNA via interacting with its exon 11 in a mutant HTT-dependent manner.

Authors:  Quan Zhao; Chen Li; Meng Yu; Yimin Sun; Jian Wang; Lixiang Ma; Xiaoli Sun; Boxun Lu
Journal:  RNA Biol       Date:  2020-01-13       Impact factor: 4.652

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.